Quantitative Western blot analysis of plasma ADAMTS13 antigen in patients with Upshaw-Schulman syndrome

Thrombosis Research

Volumn 120, Issue 3, 2007, Pages 381-386

  Ishizashi, Hiromichi ^a   Yagi, Hideo ^a   Matsumoto, Masanori ^a   Soejima, Kenji ^b   Nakagaki, Tomohiro ^b   Fujimura, Yoshihiro ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b Chemo Sero Therapeutic Research Institute   (Japan)

Author keywords

ADAMTS13; Antigen; TTP; USS

Indexed keywords

ENZYME ANTIBODY; EPITOPE; MONOCLONAL ANTIBODY; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; ENZYME BLOOD LEVEL; GENE MUTATION; HEMATOLOGIC DISEASE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; UPSHAW SCHULMAN SYNDROME; WESTERN BLOTTING;

ADAM PROTEINS; ADULT; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 9; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENES, RECESSIVE; HETEROZYGOTE; HETEROZYGOTE DETECTION; HUMANS; MALE; MUTATION; PURPURA, THROMBOTIC THROMBOCYTOPENIC;

EID: 34249931342     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2006.07.012     Document Type: Article

References (24)

1. Schulman I., Pierce M., Likens A., and Currimbhoy Z. Studies on thrombopoiesis: I. A factor in normal human plasma required for platelet production: chronic thrombocytopenia due to its deficiency. Blood 14 (1960) 947-957
2. Upshaw J.D. Congenital deficiency of a factor in normal plasma that reverses microangiopathic hemolysis and thrombocytopenia. N Engl J Med 298 (1978) 1350-1352
3. Furlan M., Robles R., Solenthaler M., Wassmer M., Sandoz P., and Lämmle B. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood 89 (1997) 3097-3103
4. Häbele J., Kwehrel B., Ritter J., Jürgens H., Lämmle B., and Furlan M. New strategies in diagnosis and treatment of thrombotic thrombocytopenic purpura: case report and review. Eur J Pediatr 158 (1999) 883-887
5. Kinoshita S., Yoshioka A., Park Y.-D., Ishizashi H., Konno M., Funado M., et al. Upshaw-Schulman syndrome revisited: a concept of congenital thrombotic thrombocytopenic purpura. Int J Hematol 78 (2001) 101-108
6. Barbot J., Costa E., Guerra M., Barreirinho M.S., Isvarlal P., Robles R., et al. Ten years of prophylactic treatment with fresh-frozen plasma in a child with chronic relapsing thrombotic thrombocytopenic purpura as a result of a congenital deficiency of von Willebrand factor-cleaving protease. Br J Haematol 113 (2001) 649-651
7. Levy G.G., Nichols W.C., Lian E.C., Foroud T., McClintick J.N., McGee B.M., et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 413 (2001) 488-494
8. Moschcowitz E. Hyaline thrombosis of the terminal arterioles and capillaries; a hitherto undescribed disease. Proc NY Pathol Soc 24 (1924) 21-24
9. Amorosi E.L., and Ultmann J.E. Thrombotic thrombocytopenic purpura: report of 16 cases and review of the literature. Medicine 45 (1966) 139-159
10. Kokame K., Matsumoto M., Soejima K., Yagi H., Ishizashi H., Funato M., et al. Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity. Proc Natl Acad Sci U S A 99 (2002) 11902-11907
11. Schneppenheim R., Budde U., Oyen F., Angerhaus D., Aumann V., Drewke E., et al. von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP. Blood 101 (2003) 1845-1850
12. Savasan S., Lee S.K., Ginsburg D., and Tsai H.M. ADAMTS13 gene mutations in congenital thrombotic thrombocytopenic purpura with previously reported normal VWF cleaving protease activity. Blood 101 (2003) 4449-4451
13. Antoine G., Zimmermann K., Plaimauer B., Grillowitzer M., Studt J.D., Lämmle B., et al. ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalozation of von Willebrand factor-cleaving protease activity by recombinant human ADAMTS13. Br J Haematol 120 (2003) 821-824
14. Matsumoto M., Kokame K., Soejima K., Miura M., Hayashi S., Fujii Y., et al. Molecular characterization of ADAMTS13 gene mutations in Japanese patients with Upshaw-Schulman syndrome. Blood 103 (2004) 1305-1310
15. Uchida T., Wada H., Mizutani M., Iwashita M., Ishihara H., Shibata T., et al. Identification of novel mutations in ADAMTS13 in an adult patient with congenital thrombotic thrombocytopenic purpura. Blood 104 (2004) 2081-2083
16. Rieger M., Ferrari S., Kremer Hovinga J.A., Konetschny C., Herzog A., Koller L., et al. Relationship between ADAMTS13 activity and ADAMTS13 antigen levels in healthy donors and patients with thrombotic microangiopathies (TMA). Thromb Haemost 95 (2006) 212-220
17. Feys H.B., Liu F., Dong N., Pareyn I., Vauterin S., Vandeputte N., et al. ADAMTS-13 plasma level determination uncovers antigen absence in acquired thrombotic thrombocytopenic purpura and ethnic differences. J Thromb Haemost 4 (2006) 955-962
18. Soejima K., Nakamura H., Hiroshima M., Morikawa W., Nozaki C., and Nakagaki T. Analysis on the molecular species and concentration of circulating ADAMTS13 in blood. J Biochem 139 (2006) 147-154
19. Kokame K., Matsumoto M., Fujimura Y., and Miyata T. VWF73, a region from D1596 to R1668 of von Willebrand factor, provides a minimal substrate for ADAMTS-13. Blood 103 (2004) 607-612
20. Kato S., Matsumoto M., Matsuyama T., Isonishi A., Hiura H., and Fujimura Y. Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS13 activity. Transfusion 46 (2006) 144-152
21. Shibagaki Y., Matsumoto M., Kokame K., Ohba S., Miyata T., Fujimura Y., et al. Novel compound heterozygote mutations (H234Q/R1206X) of the ADAMTS13 gene in an adult patient with Upshaw-Schulman syndrome showing predominant episodes of repeated acute nenal failure. Nephrol Dial Transplant 21 (2006) 1289-1292
22. Uemura M., Tatsumi K., Matsumoto M., Fujimoto M., Matsuyama T., Ishikawa M., et al. Localization of ADAMTS13 to the stellate cells of human liver. Blood 106 (2005) 922-924
23. Matsudaira P. Sequence from picomole quantities of proteins electroblotted onto polyvinylidene diffluoride membranes. J Biol Chem 262 (1987) 10035-10038
24. Crawley J.T.B., Lam J.K., Rance J.B., Mollica L.R., O'Donnell J.S., and Lane D.A. Proteolytic inactivation of ADAMTS13 by thrombin and plasmin. Blood 105 (2005) 1085-1093